English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT03369223 /

CA030-001

A Phase 1/2 First-In-Human Study Of BMS-986249 Alone And In Combination With Nivolumab In Advanced Solid Tumors

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: